| |
 |
|
Class Information
Number: 514/183
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai
Description: Subject matter which includes a compound containing a ring composed of carbon and at least one element from the group consisting of nitrogen, sulfur, selenium, tellurium and oxygen as DOAI.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/184 |
Heavy metal containing (including salts) |
555 |
| 514/191 |
Aluminum (including salts) |
54 |
| 514/192 |
1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.) |
269 |
| 514/200 |
1-thia-5-aza-bicyclo (4.2.0) octane ring containing (including dehydrogenated) (e.g., cephalosporins, etc.) |
180 |
| 514/210.01 |
Hetero ring is four-membered and includes at least one ring nitrogen |
166 |
| 514/211.01 |
Hetero ring contains seven members including nitrogen, carbon and chalcogen |
167 |
| 514/212.01 |
Hetero ring is seven-membered consisting of one nitrogen and six carbons |
229 |
| 514/218 |
Hetero ring is seven-membered consisting of two nitrogens and five carbon atoms |
853 |
| 514/222.2 |
Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members |
166 |
| 514/228.8 |
Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) |
265 |
| 514/241 |
Hetero ring is six-membered consisting of three nitrogens and three carbon atoms |
587 |
| 514/247 |
Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) |
741 |
| 514/277 |
Hetero ring is six-membered consisting of one nitrogen and five carbon atoms |
864 |
| 514/359 |
Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) |
597 |
| 514/430 |
Sulfur containing hetero ring |
107 |
| 514/449 |
Oxygen containing hetero ring |
562 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7268141 |
Xanthine phosphodiesterase V inhibitors |
Sep. 11, 2007 |
| 7268134 |
Medical devices employing triazine compounds and compositions thereof |
Sep. 11, 2007 |
| 7265114 |
Methods and compositions of novel triazine compounds |
Sep. 4, 2007 |
| 7259156 |
Geldanamycin compounds and method of use |
Aug. 21, 2007 |
| 7250157 |
Dermatological compositions and methods |
Jul. 31, 2007 |
| 7244711 |
Association of calpain inhibitors and reactive oxygen species trapping agents |
Jul. 17, 2007 |
| 7244594 |
Microbial transformation method for the preparation of an epothilone |
Jul. 17, 2007 |
| 7241773 |
3-quinuclidinyl heteroatom bridged biaryl derivatives |
Jul. 10, 2007 |
| 7241755 |
Epothilone derivatives |
Jul. 10, 2007 |
| 7241754 |
2-Desmethyl ansamycin compounds |
Jul. 10, 2007 |
| 7238715 |
Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists |
Jul. 3, 2007 |
| 7238682 |
Methods and compositions for degradation and/or inhibition of HER-family tyrosine kinases |
Jul. 3, 2007 |
| 7235542 |
Diagnosis and treatment of human kidney diseases |
Jun. 26, 2007 |
| 7235541 |
Neurokinin antagonists for use as medicaments |
Jun. 26, 2007 |
| 7232840 |
Agents for combating plant pests |
Jun. 19, 2007 |
| 7232811 |
Furosemide modulators of HM74 |
Jun. 19, 2007 |
| 7229981 |
Process for the preparation of aminoalcohol derivatives and their further conversion to (1R,4S)-4-(2-amino-6-chloro-5-formamido-4-pyrimidinyl)-amino)-2-cyclopent- enyl-1-methanol |
Jun. 12, 2007 |
| 7220778 |
Methods and devices for epithelial protection during photodynamic therapy |
May. 22, 2007 |
| 7217681 |
Pesticidal composition and method for fungal control |
May. 15, 2007 |
| 7214714 |
20-hydroxyeicosatetraenoic acid production inhibitors |
May. 8, 2007 |
| 7211587 |
Quinoline derivatives and quinazoline derivatives having azolyl group |
May. 1, 2007 |
| 7205289 |
Combinations of active ingredients with insecticidal and acaricidal properties |
Apr. 17, 2007 |
| 7205001 |
Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
Apr. 17, 2007 |
| 7202236 |
Modified release pharmaceutical formulation |
Apr. 10, 2007 |
| 7199158 |
Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
Apr. 3, 2007 |
| 7199126 |
Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase |
Apr. 3, 2007 |
| 7193706 |
Computer interfaced scanning fluorescence lifetime microscope applied to directed evolution |
Mar. 20, 2007 |
| 7192940 |
Ether compounds |
Mar. 20, 2007 |
| 7189735 |
Use of CCI-779 as an antineoplastic agent |
Mar. 13, 2007 |
| 7186709 |
Dihydropyrancarboxamides and uses thereof |
Mar. 6, 2007 |
| 7183285 |
Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase |
Feb. 27, 2007 |
| 7179800 |
Cannabinoids |
Feb. 20, 2007 |
| 7179794 |
Multivalent macrolide antibiotics |
Feb. 20, 2007 |
| 7173041 |
Polyglutamic acid-camptothecin conjugates and methods of preparation |
Feb. 6, 2007 |
| 7173021 |
Synthesis of temozolomide esters as potent anticancer pro-drugs for topical and transdermal applications in treatments of cancers |
Feb. 6, 2007 |
| 7166586 |
Sulfonamide lactam inhibitors of FXa and method |
Jan. 23, 2007 |
| 7163945 |
Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase |
Jan. 16, 2007 |
| 7163935 |
Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same |
Jan. 16, 2007 |
| 7163703 |
Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
Jan. 16, 2007 |
| 7160872 |
Methods to treat conditions mediated by chemokine receptors |
Jan. 9, 2007 |
| 7157459 |
Postoperative adjuvant chemotherapy with UFT |
Jan. 2, 2007 |
| 7157451 |
Heterocyclic dihydropyrimidine compounds |
Jan. 2, 2007 |
| 7157421 |
Piracetam and piracetam analog conjugate and a pharmaceutical composition for treatment of neuronal disorders |
Jan. 2, 2007 |
| 7157078 |
Devices and methods for eliminating termite colonies |
Jan. 2, 2007 |
| 7153864 |
Polyglutamic acid-camptothecin conjugates and methods of preparation |
Dec. 26, 2006 |
| 7153845 |
Bioadhesive progressive hydration tablets |
Dec. 26, 2006 |
| 7151096 |
Cyclic compounds and compositions as protein kinase inhibitors |
Dec. 19, 2006 |
| 7148221 |
Vanilloid receptor ligands and their use in treatments |
Dec. 12, 2006 |
| 7144878 |
Method for treating roundworm infestations in animals |
Dec. 5, 2006 |
| 7138122 |
Therapeutic systems |
Nov. 21, 2006 |
|
|
|
